Education
About Us
Working with TipRanks
Follow Us
Biocon Limited (IN:BIOCON)
:BIOCON
Total Valuation
Biocon Limited has a market cap or net worth of ₹465.31B. The enterprise value is ₹594.19B.
Market Cap₹465.31B
Enterprise Value₹594.19B
Share Statistics
Biocon Limited has 1,336,963,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,336,963,600
Owned by Insiders―
Owned by Institutions0.06%
Financial Efficiency
Biocon Limited’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 7.17%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)7.17%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee9.35M
Profits Per Employee876.13K
Employee Count16,315
Asset Turnover0.26
Inventory Turnover1.22
Valuation Ratios
The current PE Ratio of Biocon Limited is 108.8. Biocon Limited’s PEG ratio is -38.08.
PE Ratio108.8
PS Ratio2.66
PB Ratio1.88
Price to Fair Value1.88
Price to FCF23.64
Price to Operating Cash Flow0.00
PEG Ratio-38.08
Income Statement
In the last 12 months, Biocon Limited had revenue of 152.62B and earned 10.13B in profits. Earnings per share was 8.46.
Revenue152.62B
Gross Profit92.44B
Operating Income47.20B
Pretax Income18.87B
Net Income10.13B
EBITDA31.24B
Earnings Per Share (EPS)8.46
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Biocon Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.14%
Dividend Per Share₹0.5
Dividend Yield0.14%
Payout Ratio15.89%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.35
52-Week Price Change2.16%
50-Day Moving Average360.18
200-Day Moving Average352.73
Relative Strength Index (RSI)48.25
Average Volume (3m)89.96K
Important Dates
Biocon Limited upcoming earnings date is Nov 11, 2025, TBA (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend DateJul 04, 2025
Financial Position
Biocon Limited as a current ratio of 1.14, with Debt / Equity ratio of 63.52%
Current Ratio1.14
Quick Ratio0.79
Debt to Market Cap0.44
Net Debt to EBITDA4.84
Interest Coverage Ratio5.26
Taxes
In the past 12 months, Biocon Limited has paid 4.57B in taxes.
Income Tax4.57B
Effective Tax Rate0.24
Enterprise Valuation
Biocon Limited EV to EBITDA ratio is 17.85, with an EV/FCF ratio of 32.45.
EV to Sales3.65
EV to EBITDA17.85
EV to Free Cash Flow32.45
EV to Operating Cash Flow13.73
Balance Sheet
Biocon Limited has ₹60.89B in cash and marketable securities with ₹164.33B in debt, giving a net cash position of -₹103.44B billion.
Cash & Marketable Securities₹60.89B
Total Debt₹164.33B
Net Cash-₹103.44B
Net Cash Per Share-₹77.37
Tangible Book Value Per Share₹5.47
Margins
Gross margin is 60.43%, with operating margin of 30.93%, and net profit margin of 6.64%.
Gross Margin60.43%
Operating Margin30.93%
Pretax Margin12.36%
Net Profit Margin6.64%
EBITDA Margin20.47%
EBIT Margin10.11%
Analyst Forecast
The average price target for Biocon Limited is ₹353.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹353.00
Price Target Upside1.23% Upside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast6.80%
EPS Growth Forecast-75.66%